CDMOP Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 01:00):

Stats
Tagesvolumen	12 466.00
Durchschnittsvolumen	11 339.00
Marktkapitalisierung	0.00
EPS	$0.0271 ( 2022-01-30 )
Last Dividend	$0.656 ( 2021-03-12 )
Next Dividend	$0 ( N/A )
P/E	-6 265.00
ATR14	$0 (0.00%)

Avid Bioservices, Inc. Korrelation

10 Am meisten positiv korreliert
RCON	0.899
ARHS	0.896
UBFO	0.893
SRAX	0.878
FSBW	0.876
BCML	0.876
CGBD	0.874
CVLY	0.872
KBWB	0.87
EWBC	0.87

10 Am meisten negativ korreliert
CNST	-0.888
ANGI	-0.883
EPZM	-0.877
DDOG	-0.872
LFVN	-0.861
LASR	-0.861
IOVA	-0.855
FLGT	-0.854
DMRC	-0.852
ANIP	-0.851

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Avid Bioservices, Inc. Finanzdaten

Annual	2023
Umsatz:	$149.27M
Bruttogewinn:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2023
Umsatz:	$149.27M
Bruttogewinn:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2022
Umsatz:	$119.60M
Bruttogewinn:	$36.65M (30.64 %)
EPS:	$2.08

FY	2021
Umsatz:	$95.87M
Bruttogewinn:	$29.31M (30.57 %)
EPS:	$0.198

Financial Reports:

No articles found.

Avid Bioservices, Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Avid Bioservices, Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0723 - No dividend growth expected in the near future

Information

First Dividend	$0.299	2014-03-19
Last Dividend	$0.656	2021-03-12
Next Dividend	$0	N/A
Payout Date	2021-04-01
Next Payout Date	N/A
# dividends	29	--
Total Paid Out	$18.67	--
Avg. Dividend % Per Year	1.06%	--
Score	2.21	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0723
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-28)

$0 Estimate 0.00 %

Dividend Stability

0.16 Bad

Dividend Score

2.21

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$2.62	14.70%
2019	$2.62	12.90%
2020	$2.62	11.10%
2021	$0.656	2.40%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.131	1.500	-2.62	-3.93	[0 - 0.5]
returnOnAssetsTTM	-0.0394	1.200	-1.312	-1.574	[0 - 0.3]
returnOnEquityTTM	-0.0963	1.500	-2.18	-3.27	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.465	0.800	-2.68	-2.14	[1 - 3]
quickRatioTTM	0.297	0.800	-2.96	-2.37	[0.8 - 2.5]
cashRatioTTM	0.138	1.500	-0.346	-0.519	[0.2 - 2]
debtRatioTTM	0.431	-1.500	2.81	-4.22	[0 - 0.6]
interestCoverageTTM	-10.85	1.000	-5.13	-5.13	[3 - 30]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.608	2.00	-0.304	-0.608	[0 - 20]
debtEquityRatioTTM	1.090	-1.500	5.64	-8.46	[0 - 2.5]
grossProfitMarginTTM	0.0747	1.000	-2.09	-2.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.132	1.000	-4.64	-4.64	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0627	1.000	-0.763	-0.763	[0.2 - 2]
assetTurnoverTTM	0.300	0.800	-1.331	-1.065	[0.5 - 2]
Total Score				-0.942

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-25.98	1.000	-2.72	0	[1 - 100]
returnOnEquityTTM	-0.0963	2.50	-1.402	-3.27	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.608	2.00	-0.203	-0.608	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.261	1.500	-1.594	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0900	1.000	-0.250	0	[0.1 - 0.5]
Total Score				0.0723

Avid Bioservices, Inc.

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.